Interventions for basal cell carcinoma: abridged Cochrane systematic review and grade assessments.
CONCLUSIONS: Surgical interventions have lower recurrence rates and remain the gold-standard for high-risk BCC. Of the non-surgical treatments, topical imiquimod has the best evidence to support its efficacy for low-risk BCC. Priorities for future research include agreement on core outcome measures and studies with longer follow-up.
PMID: 33448328 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Thomson J, Hogan S, Leonardi-Bee J, Williams HC, Bath-Hextall FJ Tags: Br J Dermatol Source Type: research
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Dermatology | Skin | Skin Cancer | Study | UK Health